TG Therapeutics, Inc. (TGTX)

NASDAQ: TGTX · Real-Time Price · USD

52.30

-1.97 (-3.63%)

Aug 24, 2026, 9:31 AM EDT - Market open

TG Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	7,419	4,358	4,320	2,416	1,584	2,488
Market Cap Growth	65.16%	0.89%	78.80%	52.51%	-36.33%	-62.88%
Enterprise Value	7,621	4,481	4,233	2,297	1,491	2,159
Last Close Price	54.27	29.81	30.10	17.08	11.83	19.00

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	19.60	9.75	184.75	190.66	-	-
Forward PE	28.67	20.29	45.21	134.45	-	-
PS Ratio	9.63	7.07	13.13	10.34	568.84	371.96
PB Ratio	12.74	6.73	19.43	15.05	27.04	10.49
P/TBV Ratio	12.74	6.73	19.43	15.05	27.41	10.53
PEG Ratio	1.29	0.14	0.37	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	9.88	7.27	12.87	9.83	535.24	322.82
EV/EBITDA Ratio	57.90	36.32	100.79	110.20	-	-
EV/EBIT Ratio	57.95	36.34	100.95	111.33	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	1.25	0.39	1.14	0.69	1.42	0.34
Debt / EBITDA Ratio	5.45	2.03	5.74	4.82	-	-
Net Debt / Equity Ratio	0.34	0.17	-0.25	-0.66	-1.34	-0.99
Net Debt / EBITDA Ratio	1.48	0.91	-1.35	-5.10	0.36	0.68
Net Debt / FCF Ratio	11.63	-4.50	1.40	3.39	0.45	0.80
Asset Turnover	0.68	0.75	0.73	0.89	0.01	0.01
Inventory Turnover	0.93	0.85	0.51	-	-	-
Quick Ratio	3.55	2.91	4.85	5.00	3.04	4.84
Current Ratio	4.27	4.10	6.25	5.92	3.16	5.06
Return on Equity (ROE)	100.28%	102.75%	12.21%	11.57%	-151.36%	-92.03%
Return on Assets (ROA)	7.28%	9.39%	5.78%	4.93%	-47.61%	-42.87%
Return on Invested Capital (ROIC)	16.74%	26.63%	34.84%	116.52%	-	-
Return on Capital Employed (ROCE)	9.90%	13.60%	8.60%	7.50%	-155.50%	-109.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	5.74%	10.26%	0.54%	0.52%	-14.13%	-13.99%
FCF Yield	0.23%	-0.57%	-0.94%	-1.30%	-11.12%	-11.90%
Buyback Yield / Dilution	5.56%	-0.67%	-7.96%	-9.67%	-2.41%	-14.64%

SEC Filings: 10-K · 10-Q